239 related articles for article (PubMed ID: 24035997)
1. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
Kristinsson H; Smith DM; Bergsten P; Sargsyan E
Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
[TBL] [Abstract][Full Text] [Related]
2. Free fatty acid receptor 1 (FFAR1/GPR40) signaling affects insulin secretion by enhancing mitochondrial respiration during palmitate exposure.
Kristinsson H; Bergsten P; Sargsyan E
Biochim Biophys Acta; 2015 Dec; 1853(12):3248-57. PubMed ID: 26408932
[TBL] [Abstract][Full Text] [Related]
3. Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets.
Lorza-Gil E; Kaiser G; Carlein C; Hoffmann MDA; König GM; Haug S; Prates Roma L; Rexen Ulven E; Ulven T; Kostenis E; Birkenfeld AL; Häring HU; Ullrich S; Gerst F
Diabetologia; 2023 Aug; 66(8):1501-1515. PubMed ID: 37217659
[TBL] [Abstract][Full Text] [Related]
4. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
[TBL] [Abstract][Full Text] [Related]
5. Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion.
Kristinsson H; Sargsyan E; Manell H; Smith DM; Göpel SO; Bergsten P
Sci Rep; 2017 Jul; 7(1):4657. PubMed ID: 28680093
[TBL] [Abstract][Full Text] [Related]
6. 20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.
Tunaru S; Bonnavion R; Brandenburger I; Preussner J; Thomas D; Scholich K; Offermanns S
Nat Commun; 2018 Jan; 9(1):177. PubMed ID: 29330456
[TBL] [Abstract][Full Text] [Related]
7. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.
Wagner R; Kaiser G; Gerst F; Christiansen E; Due-Hansen ME; Grundmann M; Machicao F; Peter A; Kostenis E; Ulven T; Fritsche A; Häring HU; Ullrich S
Diabetes; 2013 Jun; 62(6):2106-11. PubMed ID: 23378609
[TBL] [Abstract][Full Text] [Related]
9. A novel antidiabetic drug, fasiglifam/TAK-875, acts as an ago-allosteric modulator of FFAR1.
Yabuki C; Komatsu H; Tsujihata Y; Maeda R; Ito R; Matsuda-Nagasumi K; Sakuma K; Miyawaki K; Kikuchi N; Takeuchi K; Habata Y; Mori M
PLoS One; 2013; 8(10):e76280. PubMed ID: 24130766
[TBL] [Abstract][Full Text] [Related]
10. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.
Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S
Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729
[TBL] [Abstract][Full Text] [Related]
11. Negative Effects of Cyclic Palmitate Treatment on Glucose Responsiveness and Insulin Production in Mouse Insulinoma Min6 Cells Are Reversible.
Nie Y; Li J; Jin Y; Nyomba BLG; Cattini PA; Vakili H
DNA Cell Biol; 2019 Apr; 38(4):395-403. PubMed ID: 30702352
[TBL] [Abstract][Full Text] [Related]
12. GLP-1 analogue recovers impaired insulin secretion from human islets treated with palmitate via down-regulation of SOCS2.
Chowdhury AI; Bergsten P
Mol Cell Endocrinol; 2017 Jan; 439():194-202. PubMed ID: 27566229
[TBL] [Abstract][Full Text] [Related]
13. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
[TBL] [Abstract][Full Text] [Related]
14. Identification of early biological changes in palmitate-treated isolated human islets.
Sargsyan E; Cen J; Roomp K; Schneider R; Bergsten P
BMC Genomics; 2018 Aug; 19(1):629. PubMed ID: 30134843
[TBL] [Abstract][Full Text] [Related]
15. NAD(P)H oxidase participates in the palmitate-induced superoxide production and insulin secretion by rat pancreatic islets.
Graciano MF; Santos LR; Curi R; Carpinelli AR
J Cell Physiol; 2011 Apr; 226(4):1110-7. PubMed ID: 20857410
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of GPR40 protects MIN6 β cells from palmitate-induced ER stress and apoptosis.
Wu J; Sun P; Zhang X; Liu H; Jiang H; Zhu W; Wang H
J Cell Biochem; 2012 Apr; 113(4):1152-8. PubMed ID: 22275065
[TBL] [Abstract][Full Text] [Related]
17. The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets.
Yashiro H; Tsujihata Y; Takeuchi K; Hazama M; Johnson PR; Rorsman P
J Pharmacol Exp Ther; 2012 Feb; 340(2):483-9. PubMed ID: 22106100
[TBL] [Abstract][Full Text] [Related]
18. G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids.
Del Guerra S; Bugliani M; D'Aleo V; Del Prato S; Boggi U; Mosca F; Filipponi F; Lupi R
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):22-5. PubMed ID: 19758793
[TBL] [Abstract][Full Text] [Related]
19. Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms.
Meidute Abaraviciene S; Lundquist I; Galvanovskis J; Flodgren E; Olde B; Salehi A
PLoS One; 2008 May; 3(5):e2182. PubMed ID: 18478115
[TBL] [Abstract][Full Text] [Related]
20. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C
Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
